Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ondansetron
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- Antiemetics
- ATC
- A04AA
- Strength
- 8 mg/4 mL
- Dosage form
- Injection
- Pack
- 1s x 4ml
- Registration no.
- 115403
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Hamaz Pharmaceuticals (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (1s x 4ml). Current price PKR 682.57, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Anse 8 mg/4 mL, 1s x 4ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/anse-8-mg-4-ml-115403-1s-x-4ml-hamaz-pharmaceuticals-pvt-ltd-8701/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 682.57 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 115403Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
